PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 12, 20260 citations

Solution structure of Z-form DNA bound to a curaxin ligand CBL0137.

View Full Paper
FLFeifan LiuSWShiyu WangYXYan Xu

Key Points

  • To determine the structure of Z-DNA bound to the curaxin ligand CBL0137 and its implications for cancer therapy.
  • Utilized high-resolution structural analysis to examine the Z-DNA and CBL0137 complex.
  • Employed in-cell 19F NMR to visualize the complex in living human cells.
  • Analyzed the interactions involving π-stacking and zig-zag localization.
  • Obtained the first high-resolution structure of the Z-DNA and CBL0137 complex.
  • Documented specific interactions between the ligand and Z-DNA.
  • Provided foundational knowledge for designing Z-DNA-targeting compounds.

Abstract

Z-DNA is known to be a left-handed alternative form of DNA and has important biological roles in cancer and other genetic diseases. In a recent study, we discovered CBL0137, a curaxin ligand, to enhance cancer immunotherapy by inducing Z-DNA formation and activating the Z-DNA-binding protein ZBP1. However, the structural information on binding complexes between Z-DNA and CBL0137 ligand has not reported to date. Here we present the first high-resolution structure of the complex between a Z-DNA and a curaxin ligand CBL0137. This compound is observed to interact with the Z-DNA through π-stacking and zig-zag localization. Furthermore, we directly observe the complex in living human cells using in-cell 19F NMR for the first time. This structural information provides a platform for the design of topology-specific Z-DNA-targeting compounds and is valuable for the development of new potent anticancer drugs.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Liu et al. (2026) studied this question.

synapsesocial.com/papers/698d6e5a5be6419ac0d5405ehttps://doi.org/10.1093/nar/gkag104
Ask AI
Helpful
Bookmark
Share
View Full Paper